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TO THE EDITOR
The role of lysyl hydroxylase 2 (LH2) as
an essential enzyme in the collagen
biosynthesis pathway contributes signi-
ficantly to the maintenance of skin
architecture. This enzyme is required
for the hydroxylation of specific col-
lagen lysines prior to the formation of
cross-links that stabilize the collagen
fibrils (Takaluoma et al., 2007). There
are two alternately spliced LH2 iso-
forms encoded by two distinct mRNA
transcripts that either include or ex-
clude the 63 nucleotide exon 13A
(LH2(long) and LH2(short); Yeowell
and Walker, 1999). LH2(long) mRNA
is the major LH2 splice form in skin and
has been reported to be markedly
increased in scleroderma and other
fibrotic conditions by several labora-
tories (van der Slot et al., 2003; Walker
et al., 2005; Wu et al., 2006). This is
accompanied by an overaccumulation
of cross-linked collagen that contributes
to the fibrosis (van der Slot et al., 2005).
We have examined the mechanism of
LH2(long) splicing regulation by identi-
fication of the cis-elements and trans-
acting protein factors involved. Re-
cently, we have reported that RNA-
binding proteins (TIA and Fox-2) act on
intronic sequences flanking exon 13A
(E13A) to enhance expression of fibro-
sis-associated LH2(long) (Yeowell et al.,
2009; Seth and Yeowell, 2010). We
have shown that suppression of
these trans-acting factors by siRNAs
decreased the levels of LH2(long). This
indicates the important functions that
TIA, Fox-2, and potentially other reg-
ulatory splicing factors may have in the
pathobiology of scleroderma by their
ability to increase the levels of
LH2(long). To our knowledge, this study
is the first to identify cis-elements with-
in E13A itself, which can either upre-
gulate or downregulate the expression
of LH2(long) mRNA.
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Figure 1. Substitution of the internal nucleotides of the LH2 exon 13A (E13A) dramatically changes its
alternative splicing pattern. (a) Schematic showing the WT LH2 minigene. U and D represent the
constitutively spliced upstream and downstream adenoviral exons, respectively. The black areas at either
end of E13A represent the first and last three nucleotides that were left unchanged in all substitution
constructs; Sub1 (gray), Sub2 (horizontal lines), and Sub3 (dotted). (b) P32 RT–PCR gel from the stable
transfection experiment in HEK293 cells performed in triplicate. LH2(long) and LH2(short) bands are
indicated by arrows. The gel has been cropped to show the relevant lanes next to each other. (c)
Quantification of LH2(long) is expressed as a percentage of total (LH2(long)þ LH2 (short)). Error bars
represent the mean±SD from triplicates (Po0.01).
A preliminary report of this work was presented at
the Annual Meeting of the Society for Investigative
Dermatology, Atlanta, GA (Seth P, Walker LC,
Yeowell HN: J Invest Dermatol 130:S90, May
2010)
The majority of human transcripts
are alternately spliced and this accounts
for the vast diversity of the human
proteome (Blencowe, 2006). Depend-
ing on their exonic/intronic location,
motifs on pre-mRNA that affect
alternative splicing can function either
as enhancers or silencers of exonic
splicing (ESE or ESS) or intronic
splicing (ISE or ISS) (Wang and Burge,
2008).
These motifs serve as sequence-
specific docking sites for trans-acting
protein factors that can either activate
or repress the use of proximal splice
sites by various mechanisms. To date,
the cis-elements and trans-factors iden-
tified in the regulation of the alternate
splicing of LH2 have been located
in the introns flanking the alternately
spliced E13A. To examine E13A for
possible exonic regulatory cis-ele-
ments, in this study we probed the 63
nucleotide alternately spliced exon by
sequential substitutions. This enabled
us to identify one major ESE and two
ESS within E13A that affected its spli-
cing. Using a wild-type LH2 minigene
(Seth and Yeowell, 2010), we initially
mutated the entire alternate E13A,
with the exception of six nucleo-
tides (Figure 1). As with all alternately
spliced and constitutively spliced
exons, two nucleotides at the beginning
and end of each exon are essential for
its splicing. To ensure that we were not
interfering with these essential exonic
nucleotides, we retained the wild-type
sequence for the first three and last
three nucleotides of this exon for each
of the substitutions. Moreover, the
strategy of using substitutions ensured
that the size of the exon, which can
influence the splicing pattern, was un-
changed (Baek and Green, 2005).
The accuracy of the mutations was
confirmed by sequence analysis and
the mutated minigene constructs were
stably transfected in HEK293 cells as
previously described (Seth and Yeo-
well, 2010). As shown in Figure 1, a
57 nucleotide substitution of E13A in
our prevalidated LH2 minigene (Seth
and Yeowell, 2010) from nucleotides
(þ 4 to þ60) resulted in a dramatic
decrease in the level of LH2(long)
mRNA. The substitution sequence was
derived from intron 8 of the fibroblast
growth factor receptor 2 (FGFR2) gene,
a sequence that has previously been
shown to be inert and devoid of any
splicing motifs (Baraniak et al., 2003).
To address the concern that the ob-
served decrease in LH2(long) mRNA
levels on substitution of its internal
nucleotides was independent of the
sequence used for substitutions, we
replaced the same 57 nucleotides of
LH2 E13A with two different 57 nucleo-
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Figure 2. Multiple splicing motifs exist within LH2 exon 13A (E13A). (a) Schematic showing the WT LH2 minigene with, below, E13A expanded in
more detail. The letters U and D, and the black areas at ends of E13A have been explained in legend to Figure 1. Nucleotides substituted in the
sequential substitution constructs (7.1–7.8) are shown by horizontal arrows with each asterisk representing a single nucleotide substitution. Panels b and c
are as described in legend to Figure 1. The percent inclusion of LH2(long) in all the substitutions (except 7.1) is significantly different compared
with the wild type (Po0.01).
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tide sequences. One sequence was
derived from a different part of the
FGFR2 intron 8, whereas the other was
derived from the completely unrelated
b-globin gene. Both these sequences
have been confirmed as splicing inert
and have no identifiable splicing cis-
elements (Baraniak et al., 2003; Seth
et al., 2008). As shown in Figure 1b
and quantitated in Figure 1c, a signifi-
cant decrease in LH2(long) mRNA
levels was observed in all minigene
substitutions irrespective of the origin of
the substitution sequence. These results
suggested the presence of at least
one cis-enhancer element within E13A
of LH2.
To identify the location and number
of these regulatory cis-elements affect-
ing the alternate splicing of E13A,
we examined the effect of sequential,
smaller substitutions. To accomplish
this, seven nucleotides were substituted
in the minigene constructs 7.1 to 7.7
and eight nucleotides were substituted
in 7.8 (Figure 2a). All these substitutions
were transversions, and the substituted
sequence was analyzed using bioinfor-
matics for the absence of any putative
splicing motifs. These minigene con-
structs were then stably transfected in
HEK293 cells as described. As shown
in Figure 2b and c, the results suggest
the presence of multiple cis-elements
within E13A. In comparison to the wild-
type, the mutation of the 7.2 seq-
uence virtually abolished the levels of
LH2(long) mRNA, whereas the substitu-
tion of the nucleotides in minigenes
7.4, 7.7, and 7.8 produced the oppo-
site effect of increasing the levels
of LH2(long) mRNA by over 5-fold.
The other exonic substitutions only
slightly increased LH2(long) mRNA
levels.
Overall, these substitutions strongly
suggest the presence of an ESE within
the nucleotides that were mutated in
construct 7.2 and, in addition, the
presence of two ESS in the exonic
regions mutated in the constructs 7.4,
7.7, and 7.8. As three separate exonic
regions are represented by constructs
7.2, 7.3–7.4, and 7.7–7.8, our results
reveal the presence of multiple cis-
elements within E13A that affect its
own alternative splicing.
However, it should be noted that
when both the ESE and ESS sequences
are removed by substitution of the
entire E13A (Figure 1), the overall effect
is virtual elimination of LH2(long).
This suggests that the ESE in construct
7.2 has a major role in the regulation
of LH2 alternate splicing and offers
a target for decreasing the expression
of the fibrosis-associated LH2(long)
mRNA. Potentially this could be achi-
eved by trans-splicing approaches that
are currently being tested in case of the
cystic fibrosis trans-membrane receptor
gene or by using antisense oligonucleo-
tides against the identified LH2 cis-
elements to alter the pattern of LH2
alternate splicing and directly modu-
late the levels of LH2(long) mRNA
(Song et al., 2009; Perez et al., 2010).
This approach, and the potential
knockdown of the currently unknown
trans-acting protein factor(s) that may
bind to the identified splicing motifs,
could offer fresh perspectives to ther-
apeutic strategies directed against scler-
oderma.
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